Stay updated on Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial

Sign up to get notified when there's something new on the Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T03:20:03.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The record presents details of the completed belimumab study for emphysema patients, including its eligibility criteria, treatment plan, measured outcomes, and study documents.
    Difference
    51%
    Check dated 2026-11-11T02:14:58.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:59:26.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    A site-wide notice says NIH agencies are transitioning from “Artificial Intelligence” to “Super Intelligence,” and the displayed site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:56:21.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The site's displayed revision identifier changed from v3.7.0 to v3.7.1. The study page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T01:10:02.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header and a Home button, replacing the study record content. This indicates the trial details are currently inaccessible due to an access restriction or server issue.
    Difference
    19%
    Check dated 2026-09-23T01:01:55.000Z thumbnail image

Stay in the know with updates to Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial page.